Literature DB >> 35493127

Response to a Serogroup B Meningococcal Disease Case Among Military Trainees.

Joseph E Marcus1, William N Bennett1, Dianne N Frankel2, John W Kieffer3, Theresa M Casey3, Amanda E Huston4, Courtney N Hintz5, Alexander P Keller5, Michael T Smolka5, Cynthia S Sikorski6, Heather C Yun1, Matthew J Dolan1, John L Kiley1.   

Abstract

We describe the public health response to a military trainee who developed serogroup B meningococcal disease while sharing underwater breathing equipment. Despite high transmission risk, with rapid isolation and postexposure prophylaxis administration, there were no secondary cases. This case supports carefully weighing serogroup B meningococcal vaccination in high-risk settings. Published by Oxford University Press on behalf of Infectious Diseases Society of America 2022.

Entities:  

Keywords:  Neisseria meningitidis; meningitis; meningococcal infection; serogroup B meningococcal meningitis

Year:  2022        PMID： 35493127      PMCID： PMC9043002          DOI： 10.1093/ofid/ofac162

Source DB:  PubMed          Journal:  Open Forum Infect Dis        ISSN： 2328-8957            Impact factor:   4.423


  13 in total

1.  Meningococcal carriage among a university student population - United States, 2015.

Authors:  Lucy Breakwell; Melissa Whaley; Unab I Khan; Utpala Bandy; Nicole Alexander-Scott; Lynn Dupont; Cindy Vanner; How-Yi Chang; Jeni T Vuong; Stacey Martin; Jessica R MacNeil; Xin Wang; Sarah A Meyer
Journal:  Vaccine       Date:  2017-11-26       Impact factor: 3.641

Review 2.  Vaccination with a multicomponent meningococcal B vaccine in prevention of disease in adolescents and young adults.

Authors:  Terry Nolan; Miguel O'Ryan; James Wassil; Véronique Abitbol; Peter Dull
Journal:  Vaccine       Date:  2015-07-15       Impact factor: 3.641

3.  Mbaeyi SA, Joseph SJ, Blain A, Wang X, Hariri S, MacNeil JR. Meningococcal Disease Among College-Aged Young Adults: 2014-2016. Pediatrics. 2019;143(1):e20182130.

Authors: 
Journal:  Pediatrics       Date:  2019-05       Impact factor: 7.124

4.  Surveillance snapshot: Bacterial meningitis among beneficiaries of the military health system, 1998-2013.

Authors: 
Journal:  MSMR       Date:  2013-11

5.  Genetic Diversity of Meningococcal Serogroup B Vaccine Antigens among Carriage Isolates Collected from Students at Three Universities in the United States, 2015-2016.

Authors:  Henju Marjuki; How-Yi Chang; Nadav Topaz; Melissa J Whaley; Jeni Vuong; Alexander Chen; Laurel T Jenkins; Fang Hu; Susanna Schmink; Adam C Retchless; Jennifer D Thomas; Anna M Acosta; Lucy A McNamara; Heidi M Soeters; Sarah Mbaeyi; Xin Wang
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

6.  Trends in meningococcal disease in the United States military, 1971-2010.

Authors:  Michael P Broderick; Dennis J Faix; Christian J Hansen; Patrick J Blair
Journal:  Emerg Infect Dis       Date:  2012-09       Impact factor: 6.883

7.  Meningococcal disease in US military personnel before and after adoption of conjugate vaccine.

Authors:  Michael P Broderick; Christopher Phillips; Dennis Faix
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

8.  Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015).

Authors:  Kyriaki Tryfinopoulou; Konstantinos Kesanopoulos; Athanasia Xirogianni; Nektarios Marmaras; Anastasia Papandreou; Vassiliki Papaevangelou; Maria Tsolia; Aftab Jasir; Georgina Tzanakaki
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

9.  COVID-19 Monitoring and Response Among U.S. Air Force Basic Military Trainees - Texas, March-April 2020.

Authors:  Joseph E Marcus; Dianne N Frankel; Mary T Pawlak; Theresa M Casey; Rebecca S Blackwell; Francis V Tran; Mathew J Dolan; Heather C Yun
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-05       Impact factor: 17.586

10.  University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013-2018.

Authors:  Heidi M Soeters; Lucy A McNamara; Amy E Blain; Melissa Whaley; Jessica R MacNeil; Susan Hariri; Sarah A Mbaeyi
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.